Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07254559 · ClinicalTrials.gov registry record
Integrated Predictive Monitoring for Sepsis and Necrotizing Enterocolitis
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 144
- Enrollment target
NCT07254559: Completed study, sponsored by University of Virginia.
NCT07254559 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07254559 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
Behind the scenes pilot trial in the computer lab involving chart review to use neonatal intensive care unit data to create computer models predicting sepsis and necrotizing enterocolitis in very small premature infants
Primary Outcome
Late-onset sepsis is defined as a positive blood culture treated with at least 5 days of antibiotics. Necrotizing enterocolitis was defined using Bell's staging criteria to include stage 2 or higher. The outcome was a binary indicator of whether either of these diagnoses was made or neither.
Interventions
- OTHER No Intervention: Observational Cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2024-10-31 |
What the finished NCT07254559 record still lists
NCT07254559 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention: Observational Cohort is the first listed.
NCT07254559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07254559 about?
NCT07254559 is a clinical study titled "Integrated Predictive Monitoring for Sepsis and Necrotizing Enterocolitis". Behind the scenes pilot trial in the computer lab involving chart review to use neonatal intensive care unit data to create computer models predicting sepsis and necrotizing enterocolitis in very small premature infants
What is the current status of trial NCT07254559?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2024-01-01. Estimated completion is 2024-10-31.
What interventions are being tested in trial NCT07254559?
The interventions under investigation include: No Intervention: Observational Cohort (OTHER).
Who is sponsoring clinical trial NCT07254559?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI